Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis
NCT03684759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2018-09-26
Summary
The aim of this pilot study is to demonstrate the feasibility of viral biomolecular diagnosis in sputum compared to nasopharyngeal swab in cystic fibrosis acute respiratory infection.
Conditions
- Cystic Fibrosis
- Respiratory Infection
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-24
- Primary Completion
- 2017-02-06
- Completion
- 2017-02-06
Countries
- France
Study Locations
More Related Trials
-
Near Patient Microbial Testing in Cystic Fibrosis
NCT01877707 ·Status: COMPLETED ·Phase: NA
-
Epidemiology of Anaerobic Bacteria in Cystic Fibrosis Patients: Descriptive and Non-interventional Study
NCT04879381 ·Status: COMPLETED
-
Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
NCT00004296 ·Status: COMPLETED
-
Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents
NCT00758771 ·Status: COMPLETED
-
Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.
NCT03312075 ·Status: TERMINATED
-
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
NCT01973192 ·Status: COMPLETED
-
Evaluation of the Lung Clearance Index
NCT02342951 ·Status: COMPLETED ·Phase: NA
-
Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation
NCT02480270 ·Status: COMPLETED
-
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
NCT07312734 ·Status: NOT_YET_RECRUITING
-
Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.
NCT02309229 ·Status: COMPLETED
-
Characterization of Pulmonary Microbiome in Cystic Fibrosis Patients
NCT04735679 ·Status: UNKNOWN
-
The Role of Respiratory Viruses in Exacerbations of Cystic Fibrosis in Adults
NCT01238081 ·Status: COMPLETED
-
Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis
NCT00570349 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Inflammatory and Microbiologic Markers in Sputum: Comparing Cystic Fibrosis With Primary Ciliary Dyskinesia
NCT01155115 ·Status: COMPLETED ·Phase: NA
-
A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis
NCT03056989 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis
NCT00503490 ·Status: COMPLETED ·Phase: PHASE1
-
Breath Condensate Study in Patients With Cystic Fibrosis.
NCT02056132 ·Status: COMPLETED
-
Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis
NCT05239611 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis
NCT00645788 ·Status: COMPLETED ·Phase: PHASE2
-
Airway Microbiome of Cystic Fibrosis Patients
NCT06057558 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Respiratory Muscle Training in CF Patients
NCT03190031 ·Status: COMPLETED ·Phase: NA
-
Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis
NCT00750932 ·Status: COMPLETED
-
Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis
NCT02994017 ·Status: COMPLETED ·Phase: NA
-
Impact of Respiratory Viral Infections in Infants With Cystic Fibrosis.
NCT02847156 ·Status: COMPLETED ·Phase: NA
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED